As a genetic disease caused by viral infection, the development of highly effective preventive vaccines is the most important weapon for the prevention and control of AIDS. However, so far, many AIDS vaccine developments have almost failed. In 2020, the AIDS vaccine jointly developed by Sanofi and GSK was declared a failure.
Recent studies in this cohort have confirmed a significant association between sedentary & obesity and an increased risk of early-onset colorectal cancer, indicating that at least some well-known traditional colorectal cancer risk factors may also lead to early colorectal cancer.
On August 17, GlaxoSmithKline plc (GSK) announced that the U.S. Food and Drug Administration (FDA) has accelerated the approval of its PD-1 antibody Jemperli (dostarlimab-gxly) for extended indications for the treatment of patients with relapsed or advanced solid tumors with mismatch repair defects (dMMR).
Recently, a study published in the Journal of the National Cancer Institute added evidence for the association between type 2 diabetes and cancer. Studies have shown that type 2 diabetes is associated with an increased risk of a variety of cancers, especially in the 6-8 years after suffering from type 2 diabetes, the overall cancer risk has increased by nearly 40%.
This vaccine draws on the successful experience of the hepatitis B vaccine platform, uses yeast to express the receptor binding domain (RBD) protein of the new coronavirus, and is supplemented with a new adjuvant to promote the immune response.